Evidence map›Paper›PMID 42445234›Full record

ArticleERJ open research2026

Visibility of breathlessness in fibrotic interstitial lung disease: perceptions of international healthcare professionals.

Meena Kalluri, Nanna Makholm, Thomas Skovhus Prior, Elisabeth Bendstrup, Huzaifa Adamali, Shaney Barratt, Natasha Lovell, Anne-Marie Russell, Charlotte Pooler

Abstract read
In one paragraph

Article in ERJ open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Meena KalluriDivision of Pulmonary Medicine, College of Health Sciences, University of Alberta, Edmonton, AB, Canada.ORCID https://orcid.org/0000-0003-4645-6292
Nanna MakholmCentre for Rare Lung Diseases, Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark.ORCID https://orcid.org/0000-0002-9794-0829
Thomas Skovhus PriorCentre for Rare Lung Diseases, Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark.ORCID https://orcid.org/0000-0002-0668-8454
Elisabeth BendstrupDepartment of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark.ORCID https://orcid.org/0000-0002-4238-6963
Huzaifa AdamaliBristol Interstitial Lung Disease, North Bristol NHS Trust, Southmead Hospital, Bristol, UK.ORCID https://orcid.org/0000-0002-8230-175X
Shaney BarrattTranslational Health Sciences, University of Bristol, Bristol, UK.ORCID https://orcid.org/0000-0003-3067-7349
Natasha LovellPalliative Medicine, North Bristol NHS Trust, Southmead Hospital, Bristol, UK.ORCID https://orcid.org/0000-0001-6594-799X
Anne-Marie RussellCollege of Medicine and Health, School of Health Sciences, Medical School, University of Birmingham, Birmingham, UK.ORCID https://orcid.org/0000-0002-0468-3537
Charlotte PoolerPalliative and End of Life Care, Specialty Programs, Assisted Living Alberta, Edmonton, AB, Canada.ORCID https://orcid.org/0000-0003-1186-9142

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Breathlessness is prevalent in fibrotic-interstitial lung diseases (F-ILD) but remains underrecognised and undertreated. The purpose of this study was to examine perceptions of visibility of breathlessness among healthcare professionals experienced with managing patients with F-ILD. Methods: Four focus groups and three key-informant zoom interviews were held with 28 multinational participants from diverse practice settings and health disciplines. Using a qualitative inductive approach, themes were developed and confirmed through open coding and ongoing content analysis. Results: The inevitability and invisibility of breathlessness in F-ILD were central and continuous throughout the three themes of the study: invisibility and visibility of breathlessness; complexity of breathlessness assessment; and becoming aware and prioritising breathlessness. Patients normalise and adapt to minimise their breathlessness. Exertional breathlessness and hypoxaemia are less understood by clinicians, friends, and family, contributing to its invisibility. Symptom assessment and management are complex and limited, reliance may be through an objective lens. There is a need for an easy-to integrate tool to assess and manage breathlessness. All participants were unprepared by their initial education to recognise or prioritise breathlessness as a symptom. Some sought specific training, most gained competency and awareness through role modelling and mentorship from experts. These healthcare professionals did not accept breathlessness as inevitable in F-ILD and urged others to not ignore it. Conclusions: Our study suggests perceptions of the invisibility and inevitability of breathlessness in F-ILD can change. Management of breathless patients can improve through awareness, education and training.

Identifiers

PMID42445234
PMCPMC13358659

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.